chr5-177386492-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_003052.5(SLC34A1):c.458G>T(p.Gly153Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000991 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G153A) has been classified as Pathogenic.
Frequency
Consequence
NM_003052.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC34A1 | NM_003052.5 | c.458G>T | p.Gly153Val | missense_variant | 5/13 | ENST00000324417.6 | NP_003043.3 | |
SLC34A1 | NM_001167579.2 | c.458G>T | p.Gly153Val | missense_variant | 5/9 | NP_001161051.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC34A1 | ENST00000324417.6 | c.458G>T | p.Gly153Val | missense_variant | 5/13 | 1 | NM_003052.5 | ENSP00000321424.4 | ||
SLC34A1 | ENST00000512593.5 | c.458G>T | p.Gly153Val | missense_variant | 5/9 | 2 | ENSP00000423022.1 | |||
SLC34A1 | ENST00000507685.5 | n.542G>T | non_coding_transcript_exon_variant | 5/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251404Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135890
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461874Hom.: 0 Cov.: 34 AF XY: 0.0000124 AC XY: 9AN XY: 727244
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152196Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74356
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 07, 2022 | Published functional studies demonstrate G153V results in loss of function compared to wildtype (Schlingmann et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 26787776, 31188746, 33326653, 26047794) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 15, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 153 of the SLC34A1 protein (p.Gly153Val). This variant is present in population databases (rs769409705, gnomAD 0.004%). This missense change has been observed in individuals with infantile hypercalcemia (PMID: 26047794). ClinVar contains an entry for this variant (Variation ID: 234927). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC34A1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SLC34A1 function (PMID: 26047794). This variant disrupts the p.Gly153 amino acid residue in SLC34A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 26047794). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Hypercalcemia, infantile, 2 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 26, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 06, 2016 | - - |
Hypophosphatemic nephrolithiasis/osteoporosis 1;C3150652:Fanconi renotubular syndrome 2;C4310473:Hypercalcemia, infantile, 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 05, 2021 | - - |
SLC34A1-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Nov 27, 2018 | The SLC34A1 c.458G>T (p.Gly153Val) missense variant has been reported in two studies and is found in a total of three individuals affected with either idiopathic infantile hypercalcemia or hypophosphatemia (Schlingmann et al. 2016; Braun et al. 2016). The three affected individuals include each in a homozygous, compound heterozygous, and heterozygous state. The p.Gly153Val variant was absent from 204 controls and is reported at a frequency of 0.000045 in the European (non-Finnish) population of the Genome Aggregation Database. Functional analysis in Xenopus oocytes showed that wildtype protein induced significant uptake of labeled phosphate, whereas the p.Gly153Val variant did not induce uptake significantly different from that of noninjected control cells. Transiently transfected opossum kidney cells showed complete intracellular retention of mutant protein with no detectable actin colocalization, in contrast to the wild type protein, which localized at the plasma membrane and colocalized with actin (Schlingmann et al. 2016). Based on the collective evidence, the p.Gly153Val variant is classified as likely pathogenic for SLC34A1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at